| Deep Learning-based System and AIDS-related Cytomegalovirus Retinitis (NCT04831333) | Kuifang Du | 2021-04-01 |
| Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care (NCT01431326) | Daniel Benjamin | 2011-11-01 |
| Efficacy of Elevated CD4 Counts on CMV Retinitis (NCT00091884) | National Eye Institute (NEI) | 2004-07-01 |
| Pharmacokinetics of Cidofovir During Continuous Venovenous Hemofiltration (NCT01866397) | Medical University of Vienna | 2002-03-01 |
| Longitudinal Study of Ocular Complications of AIDS (LSOCA) (NCT00000168) | Johns Hopkins Bloomberg School of Public Health | 1998-08-01 |
| Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT) (NCT00000143) | Johns Hopkins Bloomberg School of Public Health | 1997-05-01 |
| Immune Activity Against CVM Retinitis (NCT00001611) | National Eye Institute (NEI) | 1997-02-01 |
| A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes (NCT00002377) | Hoffmann-La Roche | 1997-01-01 |
| Studies of the Ocular Complications of AIDS (SOCA)--Monoclonal Antibody CMV Retinitis Trial (MACRT) (NCT00000135) | Johns Hopkins Bloomberg School of Public Health | 1995-09-01 |
| Phase II Randomized Study of Cidofovir for Peripheral Cytomegalovirus Retinitis (NCT00004794) | National Center for Research Resources (NCRR) | 1995-03-01 |
| Studies of the Ocular Complications of AIDS (SOCA)--Cytomegalovirus Retinitis Retreatment Trial (CRRT) (NCT00000134) | Johns Hopkins Bloomberg School of Public Health | 1992-12-01 |
| Ganciclovir Implant Study for Cytomegalovirus Retinitis (NCT00000118) | National Eye Institute (NEI) | 1992-10-01 |
| Studies of the Ocular Complications of AIDS (SOCA)--Foscarnet-Ganciclovir CMV Retinitis Trial (FGCRT) (NCT00000136) | Johns Hopkins Bloomberg School of Public Health | 1990-03-01 |
| Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS (NCT00001061) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Cidofovir in HIV-Infected Children With Cytomegalovirus (CMV) Disease (NCT00000881) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Viracept in AIDS Patients With Cytomegalovirus Retinitis (NCT00002169) | Agouron Pharmaceuticals | |
| CMV Retinitis Retreatment Trial (NCT00000766) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure (NCT00000691) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Randomized Comparison of Intravitreal ISIS 2922 Plus Ganciclovir Versus Ganciclovir as Treatment for Patients With Cytomegalovirus Retinitis ( CMVR ) (NCT00002156) | Ionis Pharmaceuticals, Inc. | |
| A Study of Foscarnet Plus Ganciclovir in the Treatment of Cytomegalovirus of the Eye in Patients With AIDS Who Have Already Been Treated With Ganciclovir (NCT00000970) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Multicenter Study of Oral Versus Intravenous Hydration in AIDS Patients With CMV Retinitis Treated With Foscavir (Foscarnet Sodium) (NCT00002125) | Astra USA | |
| A Comparison of ISIS 2922 Used Immediately or Later in Patients With Cytomegalovirus (CMV) of the Eyes (NCT00002355) | Ionis Pharmaceuticals, Inc. | |
| Open Label Ganciclovir Therapy for Sight- or Life-Threatening Cytomegalovirus Disease in the Immunocompromised Patient (NCT00002025) | Hoffmann-La Roche | |
| A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Eyes (NCT00001062) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Valganciclovir in Patients With CMV Retinitis and AIDS Who Cannot Take Drugs by Injection (NCT00017784) | Hoffmann-La Roche | |
| A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Cannot Use Ganciclovir (NCT00000697) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of Ganciclovir Plus Interferon Beta in Preventing the Return of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS (NCT00002299) | Hoffmann-La Roche | |
| A Pilot Study to Obtain Preliminary Information Regarding the Efficacy and Safety of the Combination of Immune Globulin and Ganciclovir as Compared to Ganciclovir Alone in the Treatment of Sight-Threatening CMV Retinitis in Patients With AIDS (NCT00001999) | American National Red Cross | |
| A Study of Valganciclovir in the Treatment of Cytomegalovirus (CMV) Retinitis in Patients With AIDS (NCT00002222) | Hoffmann-La Roche | |
| A Phase I Study of the Safety of Proleukin (Aldesleukin) in Combination With Ganciclovir and Antiretroviral Therapy in HIV Seropositive Patients With Cytomegalovirus (CMV) Retinitis (NCT00002321) | Chiron Corporation | |
| The Safety and Effectiveness of Ganciclovir Used Alone or in Combination With Granulocyte-Macrophage Colony Stimulating Factor in the Treatment of Cytomegalovirus (CMV) of the Eye in Patients With AIDS (NCT00000989) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Have Not Had Success With Ganciclovir (NCT00002301) | Astra USA | |
| An Open-Label Study of the Safety and Efficacy of Cidofovir for the Treatment of Relapsing Cytomegalovirus Retinitis in Patients With AIDS (NCT00002142) | Gilead Sciences | |
| The Safety and Effectiveness of ISIS 2922 in Patients With AIDS Who Have Cytomegalovirus (CMV) of the Eyes (NCT00002356) | Ionis Pharmaceuticals, Inc. | |
| A Comparison of HIV-Infected Patients With and Without Opportunistic (AIDS-Related) Infection (NCT00005572) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Studies of the Ocular Complications of AIDS (SOCA) CMV Retinitis Trial: Foscarnet-Ganciclovir Component (NCT00000665) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Randomized Controlled Study of the Efficacy and Safety of Maintenance Treatment With Oral Ganciclovir for Newly Diagnosed Cytomegalovirus Retinitis in People With AIDS (NCT00002257) | Hoffmann-La Roche | |
| Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV Retinitis (NCT00002070) | Schering-Plough | |
| A Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV Retinitis (NCT00000698) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study to Evaluate the Effects of Stopping Maintenance Therapy for Cytomegalovirus (CMV) Retinitis After Effective Anti-HIV Therapy (NCT00000905) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase II/III Trial of Human Anti-CMV Monoclonal Antibody MSL 109 (MACRT) (NCT00000836) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I/II Trial to Assess the Safety and Tolerance of Escalating Doses of a Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Retinitis (NCT00002016) | Sandoz | |
| A Randomized Study Comparing the Safety and Efficacy of Two Regimens of Oral Ganciclovir to Intravenous Ganciclovir Maintenance Therapy for Cytomegalovirus Retinitis in People With AIDS Who Have Received Prior Ganciclovir Therapy (NCT00002247) | Hoffmann-La Roche | |
| A Study of the Safety and Tolerance of Long-Term Therapy With Intravenous Cytovene (Ganciclovir Sodium) for Cytomegalovirus Retinitis in Persons With AIDS (NCT00002034) | Hoffmann-La Roche | |
| A Randomized, Controlled Study of Intravenous Ganciclovir Therapy for Peripheral Cytomegalovirus Retinitis in Patients With AIDS (NCT00000688) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Comparison of Two Drugs, Cidofovir and Ganciclovir, in Treating Patients With AIDS Who Have CMV Retinitis (NCT00000894) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of Ganciclovir in the Prevention of Cytomegalovirus (CMV) of the Eyes and Disease of the Stomach and Intestines in Patients With HIV (NCT00001034) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I/II Open-Labelled Trial of Intravitreal Ganciclovir Salvage Therapy for AIDS Patients With Active CMV Retinitis Who Are Intolerant of Systemic Therapy (NCT00000673) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Pharmacokinetic and Tolerance Study of 28-Day Regimens of Oral Ganciclovir (NCT00000668) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS (NCT00002437) | Gilead Sciences | |
| A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS (NCT00002432) | Astra USA | |
| A Study of ISIS 2922 in the Treatment of Advanced Cytomegalovirus Retinitis (NCT00002187) | Ionis Pharmaceuticals, Inc. | |
| A Study of Two Forms of Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS (NCT00002330) | Roche Global Development | |
| A Study of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS (NCT00002384) | Gilead Sciences | |
| An Open Label Evaluation of the Safety and Pharmacokinetics of Ganciclovir in Children (NCT00002015) | Roche Global Development | |
| An Open-Label Safety Study of Oral Ganciclovir Maintenance Treatment of CMV Retinitis in People With Limited Venous Access (NCT00002135) | Hoffmann-La Roche | |
| An Open Study of Foscarnet Treatment First Episode CMV-Retinitis in AIDS Patients (NCT00002039) | Astra USA | |
| Suppression of Cytomegalovirus Retinitis Utilizing High Dose Intravenous Acyclovir and Oral Zidovudine in Patients With AIDS (NCT00000693) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Randomized, Controlled Study of the Safety and Preventive Efficacy of Oral Ganciclovir When Used in Conjunction With An Intravitreal Ganciclovir Implant in the Treatment of Cytomegalovirus Retinitis (NCT00002134) | Roche Global Development | |